ACOs and antitrust guidance: burdensome, unclear, and expensive?
The government’s proposed guidance on antitrust scrutiny for Accountable Care Organizations may have generated more questions than answers....
Subscription required to view this article.This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: